Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cidara Therapeutics, Inc. | Director | Stock Option (right to buy) | 42.5K | Jun 22, 2023 | Direct | ||
Paratek Pharmaceuticals, Inc. | Director | Common Stock | 0 | $2.20 | Sep 21, 2023 | Direct | |
Paratek Pharmaceuticals, Inc. | Director | Stock option (right to buy) | 0 | Sep 21, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PRTK | Paratek Pharmaceuticals, Inc. | Sep 21, 2023 | 9 | $0 | 4 | Sep 21, 2023 | Director |
CDTX | Cidara Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
PRTK | Paratek Pharmaceuticals, Inc. | Feb 21, 2023 | 1 | -$13.2K | 4 | Feb 23, 2023 | Director |
PRTK | Paratek Pharmaceuticals, Inc. | Feb 8, 2023 | 1 | $0 | 4 | Feb 9, 2023 | Director |
CDTX | Cidara Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
PRTK | Paratek Pharmaceuticals, Inc. | Feb 16, 2022 | 1 | $0 | 4 | Feb 18, 2022 | Director |
CDTX | Cidara Therapeutics, Inc. | Sep 13, 2021 | 1 | $14.8K | 4 | Sep 14, 2021 | Director |
CDTX | Cidara Therapeutics, Inc. | Jun 23, 2021 | 1 | $0 | 4 | Jun 24, 2021 | Director |